Diseases, Conditions, Syndromes

Researchers apply new immune technologies in search of mono vaccine

A research lab at the University of Kansas School of Engineering and School of Pharmacy is analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr ...

Diseases, Conditions, Syndromes

Epstein-Barr virus and cancer: New tricks from an old dog

After an infection with the Epstein-Barr virus (EBV), the virus persists in the body throughout a person's lifetime, usually without causing any symptoms. About one third of infected teenagers and young adults nevertheless ...

Medical research

Young killer cells protect against infectious mononucleosis

More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus (EBV). Primary infection with this herpes virus as a young child is generally not linked to any symptoms, and usually offers life-long protection ...

Medical research

How a ubiquitous herpesvirus sometimes leads to cancer

You might not know it, but most of us are infected with the herpesvirus known as Epstein-Barr virus (EBV). For most of us, the virus will lead at worst to a case of infectious mononucleosis, but sometimes, and especially ...

Diseases, Conditions, Syndromes

Study reveals new clues to Epstein-Barr virus

Epstein-Barr virus (EBV) affects more than 90 percent of the population worldwide and was the first human virus found to be associated with cancer. Now, researchers from Beth Israel Deaconess Medical Center (BIDMC) have broadened ...

page 2 from 3